- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Nike Ratings Report.
Holding back the Dow today is Merck (NYSE: MRK), which is lagging the broader Dow index with a $1.40 decline (-2.4%) bringing the stock to $57.94. This single loss is lowering the Dow Jones Industrial Average by 10.6 points or roughly accounting for 42.4% of the Dow's overall loss. Volume for Merck currently sits at 1.6 million shares traded vs. an average daily trading volume of 10.3 million shares.Merck has a market cap of $170.94 billion and is part of the health care sector and drugs industry. Shares are up 18.5% year-to-date as of Friday's close. The stock's dividend yield sits at 3%. Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. TheStreet Ratings rates Merck as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Merck Ratings Report.